Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation (original) (raw)
Evans RM . The steroid and thyroid hormone receptor superfamily Science 1988 240: 889–895 ArticleCAS Google Scholar
Blumberg B, Evans RM . Orphan nuclear receptors: new ligands and new possibilities Genes Dev 1998 12: 3149–3155 ArticleCAS Google Scholar
Desvergne B, Wahli W . Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 1999 20: 649–688 CAS Google Scholar
Elbrecht A, Chen Y, Cullinan CA et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 Biochem Biophys Res Commun 1996 224: 431–437 ArticleCAS Google Scholar
Mukherjee R, Jow L, Croston GE, Paterniti JR . Identification, characterization and tissue distribution of human peroxisome proliferator activated receptor isoforms 1 and 2 and activation with retinoid x receptor agonists and antagonists J Biol Chem 1997 272: 18779–18789 Article Google Scholar
Barak Y, Nelson MC, Ong ES et al. PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 1999 4: 585–595 ArticleCAS Google Scholar
Willson TM, Wahli W . Peroxisome proliferator activated receptor agonists Corr Opin Chem Biol 1997 1: 235–241 ArticleCAS Google Scholar
Krey G, Braissant O, Horset FL et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol Endocrinol 1997 11: 779–791 ArticleCAS Google Scholar
Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman B, Evans RM . 15-Deoxy-12,14 prostaglandin J2 a ligand for the adipocyte determination factor PPAR Cell 1995 83: 803–812 ArticleCAS Google Scholar
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA . An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ) J Biol Chem 1995 270: 12953–12956 ArticleCAS Google Scholar
Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA . Interdomain communication regulating ligand binding by PPARγ Nature 1998 396: 377–380 ArticleCAS Google Scholar
Palmer CN, Hsu MH, Griffin HJ, Johnson EF . Novel sequence determinants in peroxisome proliferator signaling J Biol Chem 1995 270: 16114–16121 ArticleCAS Google Scholar
Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM . Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 1992 358: 771–774 ArticleCAS Google Scholar
Kliewer SA, Willson TM . The nuclear receptor PPAR-bigger than fat Curr Opin Genet Dev 1998 8: 576–581 ArticleCAS Google Scholar
Schwartz S, Raskin P, Fonseca V, Graveline JF . Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group N Engl J Med 1998 338: 861–866 ArticleCAS Google Scholar
Barroso I, Gurnell M, Crowley VE et al. Dominant negative mutations in human PPAr gamma associated with severe insulin resistance, diabetes mellitus and hypertension Nature 1999 402: 880–883 ArticleCAS Google Scholar
Demetri GD, Fletcher CD, Mueller E et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma Proc Natl Acad Sci USA 1999 196: 3951–3956 Article Google Scholar
Elstner E, Muller C, Koshizuka K et al. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proc Natl Acad Sci USA 1998 95: 8806–8811 ArticleCAS Google Scholar
Asou H, Verbeek W, Williamson E et al. Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids Int J Oncol 1999 15: 1027–1037 CASPubMed Google Scholar
Tsubouchi Y, Sano H, Kawahito Y et al. Inhibition of human lung cancer cell growth by the PPARγ agonists through induction of apoptosis Biochem Biophys Res Commun 2000 270: 400–405 ArticleCAS Google Scholar
Sarraf P, Mueller E, Smith WM et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer Mol Cell 1999 3: 799–804 ArticleCAS Google Scholar
Sarraf P, Mueller E, Jones D et al. Differentiation and reversal of malignant changes in colon cancer through PPARgamma Nat Med 1998 4: 1046–1052 ArticleCAS Google Scholar
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK . The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 1998 391: 79–82 ArticleCAS Google Scholar
Jiang C, Ting AT, Seed B . PPARγ agonists inhibit production of monocyte inflammatory cytokine Nature 199 391: 82–86 Article Google Scholar
Kawahito Y, Kondo M, Tsubouchi Y et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats J Clin Invest 2000 106: 189–197 ArticleCAS Google Scholar
Neve BP, Fruchart JC, Staels B . Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis Biochem Pharmacol 2000 60: 1245–1250 ArticleCAS Google Scholar
Chen Z, Ishibashi S, Perrey S et al. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL Arterioscler Thromb Vasc Biol 2001 21: 372–377 ArticleCAS Google Scholar
Su CG, Wen X, Bailey ST et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J Clin Invest 1999 104: 383–389 ArticleCAS Google Scholar
Pershadsingh HA, Sproul JA, Benjamin E, Finnegan J, Amin NM . Treatment of psoriasis with troglitazone therpay Arch Dermatol 1998 134: 1304–1305 ArticleCAS Google Scholar
Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM . Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 1998 93: 229–40 ArticleCAS Google Scholar
Spiegelman BM . PPARγ in monocytes-less pain, any gain? Cell 1998 93: 153–155 ArticleCAS Google Scholar
Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ . The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses J Immunol 2000 164: 1364–1371 ArticleCAS Google Scholar
Harris SG, Phipps RP . The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis Eur J Immunol 2001 4: 1098–1105 Article Google Scholar
Dean G . How many people in the world have MS? Neuroepidemiology 1994 13: 1–7 ArticleCAS Google Scholar
Clegg A, Bryant J . Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness Expert Opin Pharmacother 2001 2: 623–639 ArticleCAS Google Scholar
Wingerchuk DM, Lucchinetti CF, Noseworthy JH . Multiple sclerosis: current pathophysiological concepts Lab Invest 2001 81: 263–281 ArticleCAS Google Scholar
Raine CS . The Dale McFarlin lecture: Immunology of the MS lesion Ann Neurol 1994 36: 61–72 Article Google Scholar
Martin R, McFarland HF, McFarlin DE . Immunology of demyelinating disease Annu Rev Immunol 1992 10: 153–169 ArticleCAS Google Scholar
O’Connor KC, Bar-Or A, Hafler DA . The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis J Clin Immunol 2001 21: 81–92 Article Google Scholar
Gold R, Hartung HP, Toyka KV . Animal models for autoimmune demyelinating disorders of the nervous system Mol Med Today 2000 6: 88–91 ArticleCAS Google Scholar
Xiao BG, Link H . Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis Cell Mol Life Sci 1999 56: 5–21 ArticleCAS Google Scholar
Owens T, Sriram S . The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis Neurol Clin 1995 13: 51–73 ArticleCAS Google Scholar
Bettelli E, Nicholson E . The role of cytokines in experimental autoimmune encephalomyelitis Arch Immunol Ther Exp 2000 48: 389–398 CAS Google Scholar
Trinchieri G . Interleukin 12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity Annu Rev Immunol 1995 13: 247–251 Article Google Scholar
Bright JJ, Musuro BF, Du C, Sriram S . Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalomyelitis J Neuroimmunol 1998 82: 22–30 ArticleCAS Google Scholar
Bright JJ, Rodriguez M, Sriram S . Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced CNS demyelination J Virol 1999 73: 1637–1639 CASPubMedPubMed Central Google Scholar
Leonard JP, Waldburger KE, Goldman SJ . Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12 J Exp Med 1995 181: 381–386 ArticleCAS Google Scholar
Bright JJ, Du C, Coon M, Sriram S, Klaus SJ . Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline J Immunol 1998 161: 7015–7022 CASPubMed Google Scholar
Bright JJ, Du C, Sriram S . Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis J Immunol 1999 162: 6255–6262 CAS Google Scholar
Chung SW, Kang BY, Kim SH et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B J Biol Chem 2000 275: 32681–32687 ArticleCAS Google Scholar
Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM . Regulation of interleukin 12 p40 expression through an NF-kappa B half-site Mol Cell Biol 1995 15: 5258–5267 ArticleCAS Google Scholar
Crabtree GR . Contingent genetic regulatory events in T lymphocyte activation Science 1989 243: 355–361 ArticleCAS Google Scholar
Bacon CM, Petricoin EF III, Ortaldo JR, Rees RC, Larner AC, Johnston JA, O’Shea JJ . Interleukin 12 induces tyrosine phosphorylation and activation of Stat 4 in human lymphocytes Proc Natl Acad Sci USA 1995 92: 7307–7311 ArticleCAS Google Scholar
Jacobson NG, Szabo SJ, Weber-Nordt RM et al. Interleukin-12 signaling in Th1 cells involves tyrosine phosphorylation of Stat3 and Stat4 J Exp Med 1995 181: 1755–1762 ArticleCAS Google Scholar
Bright JJ, Sriram S . TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes J Immunol 1998 161: 1772–1777 CASPubMed Google Scholar
Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM . PPARγ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat Med 2001 7: 48–52 ArticleCAS Google Scholar
Bright JJ, Kerr LD, Sriram S . TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak1 and Stat5 in T lymphocytes J Immunol 1997 159: 175–183 CASPubMed Google Scholar
Du C, Bright JJ, Sriram S . Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice J Neuroimmunol 2001 114: 69–79 ArticleCAS Google Scholar
Walker WS, Gatewood J, Olivas E, Askew D, Havenith CE . Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells J Neuroimmunol 1995 63: 163–174 ArticleCAS Google Scholar